share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

SEC announcement ·  Mar 11 21:06
Summary by Futu AI
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 7, 2024, Klinger acquired 1,138 shares through the exercise of derivative securities. The following day, on March 8, 2024, she sold 544 shares on the open market at a price of $99.0509 per share, resulting in a total sale value of $53,883.69. After these transactions, Klinger's direct holdings in Moderna common stock amounted to 9,267 shares.
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock. On March 7, 2024, Klinger acquired 1,138 shares through the exercise of derivative securities. The following day, on March 8, 2024, she sold 544 shares on the open market at a price of $99.0509 per share, resulting in a total sale value of $53,883.69. After these transactions, Klinger's direct holdings in Moderna common stock amounted to 9,267 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.